Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels
出版年份 2023 全文链接
标题
Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels
作者
关键词
-
出版物
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Volume -, Issue -, Pages 1-6
出版商
Informa UK Limited
发表日期
2023-10-26
DOI
10.1080/00365521.2023.2269456
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Validation Study of Novel Point-of-Care Tests for Infliximab, Adalimumab and C-Reactive Protein in Capillary Blood and Calprotectin in Faeces in an Ambulatory Inflammatory Bowel Disease Care Setting
- (2023) Adriaan Volkers et al. Diagnostics
- Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives
- (2022) Konstantinos Papamichael et al. Lancet Gastroenterology & Hepatology
- Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis
- (2022) Edo H J Savelkoul et al. INFLAMMATORY BOWEL DISEASES
- Therapeutic drug monitoring in inflammatory bowel disease: implementation, utilization, and barriers in clinical practice in Scandinavia
- (2022) Kristin H. Bjørlykke et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial
- (2022) M Pfeiffer-Jensen et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases
- (2021) Silje Watterdal Syversen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases
- (2019) Konstantinos Papamichael et al. Clinical Gastroenterology and Hepatology
- Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
- (2019) Nicholas A Kennedy et al. Lancet Gastroenterology & Hepatology
- Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
- (2018) Amy Hemperly et al. CLINICAL PHARMACOKINETICS
- Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD
- (2018) Yara Nasser et al. DIGESTIVE DISEASES AND SCIENCES
- ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detections of complications
- (2018) Christian Maaser et al. Journal of Crohns & Colitis
- Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassays
- (2017) Joana Afonso et al. Therapeutic Advances in Gastroenterology
- Loss of Response to Anti-TNFs: Definition, Epidemiology and Management
- (2016) Giulia Roda et al. Clinical and Translational Gastroenterology
- Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
- (2015) Niels Vande Casteele et al. GASTROENTEROLOGY
- A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity
- (2014) R. Khanna et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment
- (2014) Per Marits et al. Journal of Crohns & Colitis
- Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
- (2009) Adedigbo A. Fasanmade et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now